spacer
spacer

Jump to: InterProScan Databases Documentation FTP site Help Advanced search

InterPro: IPR017927 Ferredoxin reductase-type FAD-binding domain

Protein matchesHelp
UniProtKB
Matches:
10160 proteins
AccessionHelp IPR017927 Fd_Rdtase_FAD-bd
TypeHelp Domain
SignaturesHelp
InterPro RelationshipsHelp
Parent IPR017938 Riboflavin synthase-like beta-barrel
Children IPR003097 FAD-binding, type 1
IPR008333 Oxidoreductase, FAD-binding domain
IPR013112 FAD-binding 8
IPR013113 FAD-binding 9, siderophore-interacting
Found in IPR012146 Ferredoxin--NADP reductase
GO Term annotationHelp
Process GO:0055114 oxidation reduction
Function GO:0016491 oxidoreductase activity
InterPro annotation
BioMart Logo Entry Details in BioMart
AbstractHelp

Flavoenzymes have the ability to catalyse a wide range of biochemical reactions. They are involved in the dehydrogenation of a variety of metabolites, in electron transfer from and to redox centres, in light emission, in the activation of oxygen for oxidation and hydroxylation reactions [1]. About 1% of all eukaryotic and prokaryotic proteins are predicted to encode a flavin adenine dinucleotide (FAD)-binding domain [2].

According to structural similarities and conserved sequence motifs, FAD-binding domains have been grouped in three main families: (i)the ferredoxin reductase (FR)-type FAD-binding domain, (ii) the FAD-binding domains that adopt a Rossmann fold and (iii) the PCMH-type FAD-binding domain [3].

The FAD cofactor consists of adenosine monophosphate (AMP) linked to flavin mononucleotide (FMN) by a pyrophosphate bond. The AMP moiety is composed of the adenine ring bonded to a ribose that is linked to a phosphate group. The FMN moiety is composed of the isoalloxazine-flavin ring linked to a ribitol, which is connected to a phosphate group. The flavin functions mainly in a redox capacity, being able to take up two electrons from one substrate and release them two at a time to a substrate or coenzyme, or one at a time to an electron acceptor. The catalytic function of the FAD is concentrated in the isoalloxazine ring, whereas the ribityl phosphate and the AMP moiety mainly stabilise cofactor binding to protein residues [1].

The structural core of all FR family members is well conserved. The FAD-binding fold characteristic of the FR family is a cylindrical beta-domain with a flattened six-stranded antiparallel beta-barrel organised into two orthogonal sheets (B1-B2-B5 and B4-B3-B6) separated by one alpha-helix [4]. The cylinder is open between strands B4 and B5 which makes space for the isoalloxazine and ribityl moieties of the FAD. One end of the cylinder is covered by the only helix of the domain, which is essential for the binding of the pyrophosphate groups of the FAD. The FR family contains two conserved motifs, one (R-x-Y-[ST]) located in B4 where the invariant positively charge Arg residue forms hydrogen bonds to the negative pyrophosphate oxygen atom. The other conserved sequence motif is G-x(2)-[ST]-x(2)-L-x(5)-G-x(7)-P-x-G, which is part of H1-B6 and is known as the phosphate-binding motif [3, 4].

Structural linksHelp
PDB - click here
Database linksHelp
Enzyme: EC:1

Taxonomic coverageHelp

Overlapping InterPro entriesHelp
IPR017927 Numbers of overlapping proteins Average numbers of overlapping amino acids

Example proteinsHelp
O61213 Dual oxidase 1

P00387 NADH-cytochrome b5 reductase 3

P16603 NADPH--cytochrome P450 reductase

P29477 Nitric oxide synthase, inducible

Q27571 Nitric oxide synthase

More proteins


Example Proteins Key


InterPro entry accession number/name and structure databases Colour code
IPR008333 Oxidoreductase, FAD-binding domain
IPR001834 NADH:cytochrome b5 reductase (CBR)
IPR013121 Ferric reductase, NAD binding
IPR015702 NADPH Cytochrome P450 Reductase
IPR008254 Flavodoxin/nitric oxide synthase
IPR003097 FAD-binding, type 1
IPR011992 EF-hand-like domain
IPR002007 Haem peroxidase, animal
IPR002048 Calcium-binding EF-hand
IPR004030 Nitric oxide synthase, oxygenase domain
IPR013112 FAD-binding 8
IPR013130 Ferric reductase-like transmembrane component, N-terminal
IPR001094 Flavodoxin-like
IPR001433 Oxidoreductase FAD/NAD(P)-binding
IPR017927 Ferredoxin reductase-type FAD-binding domain
IPR001709 Flavoprotein pyridine nucleotide cytochrome reductase
IPR017938 Riboflavin synthase-like beta-barrel
IPR018249 EF-HAND 2
IPR010255 Haem peroxidase
IPR012144 Nitric-oxide synthase
IPR019791 Haem peroxidase, animal, subgroup
ModBase
SWISS-MODEL
PDB Chain
CATH Domain
SCOP Domain

PublicationsHelp
1. Fraaije MW, Mattevi A.
Flavoenzymes: diverse catalysts with recurrent features.
Trends Biochem. Sci. 25 126-32 2000 [PubMed: 10694883]
http://dx.doi.org/10.1016/S0968-0004(99)01533-9
2. Mattevi A.
To be or not to be an oxidase: challenging the oxygen reactivity of flavoenzymes.
Trends Biochem. Sci. 31 276-83 2006 [PubMed: 16600599]
http://dx.doi.org/10.1016/j.tibs.2006.03.003
3. Dym O, Eisenberg D.
Sequence-structure analysis of FAD-containing proteins.
Protein Sci. 10 1712-28 2001 [PubMed: 11514662]
http://dx.doi.org/10.1110/ps.12801
4. Sridhar Prasad G, Kresge N, Muhlberg AB, Shaw A, Jung YS, Burgess BK, Stout CD.
The crystal structure of NADPH:ferredoxin reductase from Azotobacter vinelandii.
Protein Sci. 7 2541-9 1998 [PubMed: 9865948]
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=9865948&action=stream&blobtype=pdf

Additional ReadingHelp
Nogues I, Perez-Dorado I, Frago S, Bittel C, Mayhew SG, Gomez-Moreno C, Hermoso JA, Medina M, Cortez N, Carrillo N.
The ferredoxin-NADP(H) reductase from Rhodobacter capsulatus: molecular structure and catalytic mechanism.
Biochemistry 44 2005 11730-40 [PubMed: 16128574]
http://dx.doi.org/10.1021/bi0508183
Nascimento AS, Catalano-Dupuy DL, Bernardes A, Neto Mde O, Santos MA, Ceccarelli EA, Polikarpov I.
Crystal structures of Leptospira interrogans FAD-containing ferredoxin-NADP+ reductase and its complex with NADP+.
BMC Struct. Biol. 7 2007 69 [PubMed: 17958910]
http://dx.doi.org/10.1186/1472-6807-7-69
Mayoral T, Martinez-Julvez M, Perez-Dorado I, Sanz-Aparicio J, Gomez-Moreno C, Medina M, Hermoso JA.
Structural analysis of interactions for complex formation between Ferredoxin-NADP+ reductase and its protein partners.
Proteins 59 2005 592-602 [PubMed: 15789405]
http://dx.doi.org/10.1002/prot.20450
Wang A, Zeng Y, Han H, Weeratunga S, Morgan BN, Moenne-Loccoz P, Schonbrunn E, Rivera M.
Biochemical and structural characterization of Pseudomonas aeruginosa Bfd and FPR: ferredoxin NADP+ reductase and not ferredoxin is the redox partner of heme oxygenase under iron-starvation conditions.
Biochemistry 46 2007 12198-211 [PubMed: 17915950]
http://dx.doi.org/10.1021/bi7013135
Cremades N, Bueno M, Toja M, Sancho J.
Towards a new therapeutic target: Helicobacter pylori flavodoxin.
Biophys. Chem. 115 2005 267-76 [PubMed: 15752617]
http://dx.doi.org/10.1016/j.bpc.2004.12.045
spacer
spacer
InterPro 23.1